Semaglutide
Semaglutide is a medication prescribed to help manage weight loss and diabetes. It mimics the effects of glucagon-like peptide-1 (GLP-1), which increases insulin production, impacts blood sugar, and supports healthy metabolism. Semaglutide has been approved by the FDA under various brand names for the treatment of chronic weight management and obesity.
Suggested Dosage: 0.25mg to 2.5mg of Semaglutide, injected weekly as a subcutaneous injection or oral capsule. Semaglutide must be titrated or started at a lower dose and gradually increased over time, to help the body adjust to the medication.
Patient protocols may vary. Semaglutide may be combined with other medications and supplements as appropriate under the supervision of a provider.
Patients must have a consult to review medical history, current medications, and labs before starting treatment ($99).
Each month patients will be expected to schedule an appointment online to discuss a need for medication titration. as the dose of Semaglutide increases the monthly cost of medication will also increase..
*Treatment for weight loss not FDA approved.